Literature DB >> 1777946

Calcium-dependent and calcium-independent protease activities in skeletal muscle during sepsis.

J Bhattacharyya1, K Thompson, M M Sayeed.   

Abstract

Sepsis was produced in rats by implanting into their abdominal cavities fecal pellets containing Escherichia coli (10(2) colony-forming units [CFU]) and Bacteroides fragilis (10(4) CFU). Control rats were implanted with sterile pellets. A febrile response and hyperlactacidemia marked the onset of the septic injury. Control and septic rats were killed 24 and 48 hr after implantations, and posterior leg muscles were removed. Muscles were homogenized to prepare soluble fractions containing calcium-independent lysosomal (cathepsins B and L) and calcium-dependent cytosolic (calpain) proteases. Cathepsin and calpain activities were then assayed using standard procedures. There were no alterations in cathepsins B or L activities during sepsis. Calpain activity in septic muscle was significantly higher than that in control muscles. In vitro calpain sensitivity to Ca2+ was also higher in septic muscle than in controls. The cysteine protease inhibitor leupeptin caused a quantitatively greater inhibition of calpain activity in septic than in control muscles. These data indicate that whereas sepsis has no effect on Ca(2+)-insensitive lysosomal proteases, it is associated with an elevation of the Ca(2+)-dependent cytosolic protease activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777946

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  10 in total

Review 1.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

2.  Cleavage of plasma high molecular weight kininogen in surgical ICU patients.

Authors:  T S Karlsrud; L Buø; A O Aasen; H T Johansen
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

Review 3.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

4.  Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis?

Authors:  S K Song; I E Karl; J J Ackerman; R S Hotchkiss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia.

Authors:  R S Hotchkiss; I E Karl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.

Authors:  G Tiao; J M Fagan; N Samuels; J H James; K Hudson; M Lieberman; J E Fischer; P O Hasselgren
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.

Authors:  L Voisin; D Breuillé; L Combaret; C Pouyet; D Taillandier; E Aurousseau; C Obled; D Attaix
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

Review 8.  Sepsis-induced myopathy.

Authors:  Leigh Ann Callahan; Gerald S Supinski
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

Review 9.  Mitochondria-meditated pathways of organ failure upon inflammation.

Authors:  Andrey V Kozlov; Jack R Lancaster; Andras T Meszaros; Adelheid Weidinger
Journal:  Redox Biol       Date:  2017-05-25       Impact factor: 11.799

10.  Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and functional changes in severe sepsis.

Authors:  Mara R N Celes; Lygia M Malvestio; Sylvia O Suadicani; Cibele M Prado; Maria J Figueiredo; Erica C Campos; Ana C S Freitas; David C Spray; Herbert B Tanowitz; João S da Silva; Marcos A Rossi
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.